Budesonide Suspension
Product Images NDC 59651-585

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 59651-585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Budesonide Fig1)

A line graph showing the mean change from baseline in nighttime asthma symptoms over a 12-week period. It compares four groups: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily, with values plotted at baseline and at several intervals up to 12 weeks.*

FDA Label Image

Figure-2 (Budesonide Fig2)

A line graph showing the mean change from baseline in nighttime asthma symptoms over a 12-week period. The x-axis represents time intervals from baseline through weeks 0-2, 2-4, 4-6, 6-8, 8-10, and 10-12, while the y-axis shows changes from 0.1 to -0.6. Three lines represent different budesonide doses: 0.25 mg twice daily, 0.5 mg twice daily, and placebo.*

FDA Label Image

Figure-3 (Budesonide Fig3)

A line graph showing mean change from baseline in nighttime asthma symptoms over a 12-week period. The x-axis represents time from baseline through Weeks 0-2, 2-4, 4-6, 6-8, 8-10, and 10-12. The y-axis shows mean change from baseline in symptom scores. Five lines indicate different treatment groups: placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily doses, demonstrating trends in symptom reduction over time.*

FDA Label Image

Figure-4 (Budesonide Fig4)

Illustration showing the removal of a single ampule from a strip of multiple sealed ampules, intended for use with a respiratory inhalation suspension product. The image demonstrates handling technique for a 0.5 mg/2 mL budesonide suspension by Aurobindo Pharma Limited.*

FDA Label Image

Figure-5 (Budesonide Fig5)

An instructional illustration showing a hand holding a bottle of Budesonide suspension for respiratory inhalation. The image demonstrates shaking the bottle with an arrow indicating the motion, suggesting how to prepare the suspension before use.*

FDA Label Image

Figure-6 (Budesonide Fig6)

An instructional illustration showing a hand opening an ampule by snapping off the top. The diagram includes an arrow indicating the direction to apply force to break the ampule neck.*

FDA Label Image

Figure-7 (Budesonide Fig7)

An instructional illustration showing a hand holding a vial or ampule and another hand preparing to insert it into an inhalation device, likely demonstrating how to load the Budesonide suspension for respiratory inhalation.*

FDA Label Image

Package Label.principal Display Panel-0.5 mg Per 2ml (Printed Triple Laminated Pouch Label)

Label for Budesonide Inhalation Suspension 0.5 mg per 2 mL single-dose ampules. The product is for inhalation only and comes in a pouch containing five 2 mL ampules. Distributed by Aurobindo Pharma USA, Inc., the label includes storage instructions, usage warnings, and a barcode, with branding by Aurobindo.*

FDA Label Image

Package Label.principal Display Panel-0.5 mg Per 2ml (Carton)

Packaging label for Budesonide Inhalation Suspension 0.5 mg per 2 mL by Aurobindo Pharma Limited. The carton contains 30 single-dose ampules, each 2 mL. The label states it is for inhalation only and provides storage instructions. Includes illustrated patient instructions for use of the inhalation suspension with a nebulizer.*

FDA Label Image

Budesonide-structure (Budesonide Str)

Chemical structure diagram of budesonide, showing its steroidal backbone with labeled carbon and oxygen atoms, hydroxyl groups, and ester linkages as part of its molecular structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.